BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21099435)

  • 1. Pharmacokinetics of colistin in an adolescent boy with extensive burn injury.
    Healy DP; Sombun AD; Gardner JC; Good K; Durkee PJ; Toner L; Rieman MT; Neely AN; Kagan RJ
    J Burn Care Res; 2011; 32(1):e7-11. PubMed ID: 21099435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.
    Akers KS; Rowan MP; Niece KL; Stewart IJ; Mende K; Cota JM; Murray CK; Chung KK
    Antimicrob Agents Chemother; 2015 Jan; 59(1):46-52. PubMed ID: 25313211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome analysis of colistin-treated burn center patients.
    Wilkinson RE; Hill DM; Hickerson WL
    Burns; 2017 Sep; 43(6):1244-1249. PubMed ID: 28410932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline.
    Taccone FS; Rodriguez-Villalobos H; De Backer D; De Moor V; Deviere J; Vincent JL; Jacobs F
    Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):257-60. PubMed ID: 16572310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
    Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; SorlĂ­ L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients.
    Corcione S; Baietto L; Malvasio V; Stella M; Di Perri G; D'Avolio A; De Rosa FG
    J Antimicrob Chemother; 2017 Jan; 72(1):319-321. PubMed ID: 27591295
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
    Katragkou A; Roilides E
    J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Acinetobacter baumannii infection in critically ill burned patients.
    Trottier V; Segura PG; Namias N; King D; Pizano LR; Schulman CI
    J Burn Care Res; 2007; 28(2):248-54. PubMed ID: 17351441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.
    Dersch R; Robinson E; Beume L; Rauer S; Niesen WD
    Neurol Sci; 2015 Apr; 36(4):633-4. PubMed ID: 25501805
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
    Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
    Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin.
    Michalopoulos A; Kasiakou SK; Rosmarakis ES; Falagas ME
    Scand J Infect Dis; 2005; 37(2):142-5. PubMed ID: 15764204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic analysis of colistin in burn patients.
    Lee J; Han S; Jeon S; Hong T; Song W; Woo H; Yim DS
    Antimicrob Agents Chemother; 2013 May; 57(5):2141-6. PubMed ID: 23439640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
    Lee CH; Tang YF; Su LH; Chien CC; Liu JW
    Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
    Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.